A recent article in Molecular Cancer Therapeutics shows the anticancer potential of an inhibitor of ubiquitin-specific protease 7 (USP7).
28 August, 2009
Cleveland BioLabs, Inc. announced recently that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its U.S. Patent Application Number 11/421,918, titled ‘Modulating Apoptosis’. Allowed claims cover the method of protecting a mammal from radiation using flagellin or its derivatives, including Protectan CBLB502.
26 August, 2009
For the first time, scientists have used a genetically engineered ‘friendly’ bacterium to deliver a therapy.
21 August, 2009
A new experimental treatment for multiple sclerosis completely reverses the devastating autoimmune disorder in mice and might work exactly the same way in humans, say researchers at the Jewish General Hospital Lady Davis Institute for Medical Research and McGill University in Montreal.
20 August, 2009
New technology designed to analyze large numbers of novel marine microbes could lead to more efficient and greener ways to manufacture new drugs for conditions such as epilepsy, diabetes, and flu and other viruses, as well as improving the manufacture of other products, such as agrochemicals.
14 August, 2009
A compound initially isolated from a soft coral (Capnella imbricata), collected at Green Island off Taiwan, could lead scientists to develop a new set of treatments for neuropathic pain.
05 August, 2009